
Publication
Securities regulators amend investment limits for offering memorandum exemption
Canadian securities regulators have made changes to give investors greater access to exempt markets.
Global | Publication | March 2017
NHS England has published new guidelines on managing conflicts of interest. The guidance will come into force on 1 June 2017. It will be applicable to Clinical Commissioning Groups, NHS Trusts and NHS Foundation Trusts, and NHS England.
The guidance covers common situations which can give rise to risk of conflicts of interest including gifts, hospitality and providing expertise outside employment, by:
Organisations should require staff to comply with the guidance and to proactively declare interests. An organisation will consider a range of actions from deciding no action is warranted to removing an individual from their role altogether if the conflict is so significant that they are unable to operate effectively in it.
The NHS England guidance has been aligned with The Association of the British Pharmaceutical Industry (ABPI) Code of Practice, particularly as it relates to the principles and rules for gifts and hospitality. Organisations are also required to seek to ensure that staff are subject to wider transparency initiatives such as the ABPI’s Disclosure UK.
Disclosure UK, launched in June 2016, is a searchable database detailing transfers of values made to healthcare professionals and healthcare organisations by pharmaceutical companies. The database is the means by which UK pharmaceutical companies comply with their transparency obligations under the ABPI Code of Practice.
Publication
Canadian securities regulators have made changes to give investors greater access to exempt markets.
Publication
Another compliance deadline is approaching under the federal Pay Equity Act – federally regulated employers are required to file an annual statement with the Office of the Pay Equity Commissioner on or before June 30, 2025, if they posted a pay equity plan in the previous year.
Subscribe and stay up to date with the latest legal news, information and events . . .
© Norton Rose Fulbright LLP 2025